Form 4 for CBT CABOT CORP
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-16 · accession 0001209191-22-010579 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-16 | CBT | Kalkstein Hobart | SVP | S - Sale+OE | $73.50 | -11.8K | 52.8K | -18% | -$867.7K |
| D | 2022-02-17 | 2022-02-16 | CBT | Kalkstein Hobart | SVP | M - OptEx | $50.46 | +11.8K | 64.6K | +22% | +$595.7K |
| D | 2022-02-17 | 2022-02-16 | CBT | Kalkstein Hobart | SVP | M - OptEx | $50.46 | +11.8K | 0 | New | +$595.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-16 | S | D | 11,805 | $73.50 | 52,785 | D | — | — | (F1) The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.50 to $73.55, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-02-16 | M | A | 11,805 | $50.46 | 64,590 | D | — | — | |
| 3 | Derivative | Stock Options | 2022-02-16 | M | A | 11,805 | $50.46 | 0 | D | $50.46 · — to 2026-11-10 | 11,805 Cabot Corp | (F2) 18,558 shares were subject to the option. The option vested over a three year period as follows: 30% on November 11, 2017, 30% on November 11, 2018 and 40% on November 11, 2019. |